Surufatinib plus toripalimab in advanced soft tissue sarcoma (STS): Results from a multicenter, single-arm, basket study.

Authors

null

Ying Cheng

Department of Oncology, Jilin Cancer Hospital, Changchun, China

Ying Cheng , Xing Zhang , Ming Lu , Si Shi , Feng Ye , Zhendong Chen , Dongmei Ji , Lijie Song , Fei Yin , Haiyan Shi , Jinghong Zhou , Panfeng Tan , Songhua Fan , Qian Xu , Michael Shi , Weiguo Su

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Breakthrough

Session Type

Poster Session

Session Title

Poster Session A

Track

Gastrointestinal Cancer,Central Nervous System Tumors,Developmental Therapeutics,Genitourinary Cancer,Quality of Care,Healthcare Equity and Access to Care,Population Health,Viral-Mediated Malignancies

Sub Track

Targeted Therapies

Clinical Trial Registration Number

NCT04169672

Citation

J Clin Oncol 42, 2024 (suppl 23; abstr 42)

DOI

10.1200/JCO.2024.42.23_suppl.42

Abstract #

42

Poster Bd #

B5

Abstract Disclosures